Impact of Periodontal Disease on Outcomes in Diabetes
Contemporary Clinical Trials
First page number:
Last page number:
The prevalence of periodontal disease (POD) among adults aged 30years and older in the United States is reported to be more than 47%, with higher prevalence seen among patients with diabetes mellitus (DM). POD has been associated with systemic inflammation, a known risk factor for cardiovascular and bone disease, both of which are more common in patients with DM. However, there is mixed evidence that treatment of POD reduces inflammation, improves DM control, and reduces DM complications. Our study objectives are to assess factors associated with POD in patients with DM and determine the impact of POD treatment on inflammation and bone turnover biomarkers associated with complications of DM.
Bone turnover biomarkers; Diabetes complications; Glycemic control; Inflammation biomarkers; Periodontal disease
Impact of Periodontal Disease on Outcomes in Diabetes.
Contemporary Clinical Trials, 41